In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.
Nicholas Rebold, PharmD, BCIDP, AAHIVP, MPH
Advertisement
Nicholas Rebold is a clinical assistant professor at Howard University College of Pharmacy and the infectious diseases pharmacist for Howard University Hospital in Washington, DC. He recently completed an infectious diseases fellowship at the Anti-infective Research Laboratory in Detroit, MI.
Articles by Nicholas Rebold, PharmD, BCIDP, AAHIVP, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
Practically Expanding AI's role in Infectious Diseases
3
Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence
4
ID Week Brings Education, Networking and Conference Events Altogether Into One Conference
5
